Assurer l'indépendance et la croissance pérenne du groupe
Pour créer de la valeur sur du long terme, nous diversifions et gérons les réserves financières du groupe à travers les marchés cotés ou privés, avec une forte ambition de responsabilité. Nos activités s’articulent autour de 7 domaines principaux.
Les activités
Private Equity Direct
Accompagner des PMEs de croissance
Dette privée
Apporter des financements rapides et flexibles
Fonds Private Equity
Développer un portefeuille diversifié et équilibré
Participations long terme
S’associer durablement à des visionnaires
Finance
Construire un portefeuille solide, équilibré et adapté à l'environnement mondial
Immobilier
Gérer et optimiser un patrimoine immobilier direct et indirect
Compliance & Operations
Assurer la conformité réglementaire des investissements du groupe et la gestion des opérations
Membres de la Direction
Découvrez les membres de la Direction qui guident & apportent une vision long terme aux différentes activités
Direction Responsible Capital Management
![](https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-768x0-c-default.jpg 768w)
Thierry Mauvernay
Thierry Mauvernay
President, Delegate of the Board, Après-demain SA![Director, Private Equity Department, Debiopharm Investment S.A. Debiopharm-Alexandra-LeCoz-Sanchez](https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-768x0-c-default.jpg 768w)
Alexandra Le Coz Sanchez
Alexandra Le Coz Sanchez
Vice President, Capital Management![Chief Investment Officer, Financial department, Debiopharm Investment S.A. Debiopharm-Samuel-Moulin](https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_SMN1-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_SMN1-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_SMN1-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_SMN1-768x0-c-default.jpg 768w)
Samuel Moulin
Samuel Moulin
Director, Finance Department & Chief Investment Officer![](https://www.apres-demain.com/wp-content/uploads/2020/03/DAD_Sebastien-Beth_2022-2-320x0-c-default.png 320w, https://www.apres-demain.com/wp-content/uploads/2020/03/DAD_Sebastien-Beth_2022-2-512x0-c-default.png 512w, https://www.apres-demain.com/wp-content/uploads/2020/03/DAD_Sebastien-Beth_2022-2-542x0-c-default.png 542w, https://www.apres-demain.com/wp-content/uploads/2020/03/DAD_Sebastien-Beth_2022-2-768x0-c-default.png 768w)
Sébastien Beth
Sébastien Beth
CEO, S.I.GN Partenaires SA, Director, Private Equity Department![Director, Real Estate department, Debiopharm Investment S.A. Debiopharm-Benjamin-Favre](https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_BFA2-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_BFA2-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_BFA2-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_BFA2-768x0-c-default.jpg 768w)
Benjamin Favre
Benjamin Favre
CEO, Next Immobilier SA, Director, Real Estate Departement![](https://www.apres-demain.com/wp-content/uploads/2020/10/AprèsDemain-Sophie_Marguerat3-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2020/10/AprèsDemain-Sophie_Marguerat3-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2020/10/AprèsDemain-Sophie_Marguerat3-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2020/10/AprèsDemain-Sophie_Marguerat3-768x0-c-default.jpg 768w)
Sophie Marguerat
Sophie Marguerat
Director, Compliance & OperationsComité stratégique
![](https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2024/05/Apres-demain_Thierry_Mauvernay-v7-768x0-c-default.jpg 768w)
Thierry Mauvernay
Thierry Mauvernay
President, Delegate of the Board, Après-demain SA![Chief Executive Officer, Debiopharm International S.A. Debiopharm-Valérie-Calvayrac](https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_VCC2-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_VCC2-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_VCC2-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_VCC2-768x0-c-default.jpg 768w)
Valérie Calvayrac
Valérie Calvayrac
Asset Diversification Strategic Leader![Director, Private Equity Department, Debiopharm Investment S.A. Debiopharm-Alexandra-LeCoz-Sanchez](https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/08/DEBM_Site18_PhotosTeam_ACS1-768x0-c-default.jpg 768w)
Alexandra Le Coz Sanchez
Alexandra Le Coz Sanchez
Vice President, Capital Management![Debiopharm-Committee-Arturo-Bris](https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BAR-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BAR-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BAR-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BAR-768x0-c-default.jpg 768w)
Arturo Bris
Arturo Bris
Membre![Debiopharm-Committee-Ferdinando-Mercuri](https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_FME-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_FME-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_FME-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_FME-768x0-c-default.jpg 768w)
Ferdinando Mercuri
Ferdinando Mercuri
Membre![Debiopharm-Committe-Renaud-de-Planta](https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_RDE-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_RDE-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_RDE-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_RDE-768x0-c-default.jpg 768w)
Renaud de Planta
Renaud de Planta
Membre![Debiopharm-Committee-Charles-Ruggieri](https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_STU-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_STU-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_STU-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_STU-768x0-c-default.jpg 768w)
Charles Ruggieri
Charles Ruggieri
Membre![Debiopharm-Committee-Bertrand-Rambaud](https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BRA-320x0-c-default.jpg 320w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BRA-512x0-c-default.jpg 512w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BRA-542x0-c-default.jpg 542w, https://www.apres-demain.com/wp-content/uploads/2018/09/DEBM_Site18_PhotosTeam_BRA-768x0-c-default.jpg 768w)
Bertrand Rambaud